Prenatal and early childhood exposure to the chemical solvent tetrachloroethylene (PCE) found in drinking water may be associated with long-term visual impairments, particularly in the area of color discrimination, a new ...
Jul 11, 2012
0
0
(Medical Xpress) -- Two UC Irvine ophthalmologists are the first in Orange County to implant a miniature telescope in the eyes of patients with end-stage age-related macular degeneration, the leading cause of blindness among ...
Jun 26, 2012
0
0
iPhones and other smartphones can be a huge help to the visually impaired, but few vision doctors are recommending them to patients, according to a study co-authored by a Loyola University Chicago Stritch School of Medicine ...
May 16, 2012
0
0
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual's risk of developing the eye condition Fuchs' dystrophy. The findings ...
May 7, 2012
0
1
Despite more than 200 000 eye doctors in practice around the globe, capacity is not keeping pace with the growing demands of ageing populations and the current needs of developing countries, finds research published online ...
Mar 27, 2012
0
0
Mayo Clinic researchers have trained mouse immune systems to eradicate skin cancer from within, using a genetic combination of human DNA from melanoma cells and a cousin of the rabies virus. The strategy, called cancer immunotherapy, ...
Mar 19, 2012
0
0
A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, ...
Mar 7, 2012
0
0
One of the most difficult things optometrists and ophthalmologists must tell a patient is that he or she has an eye disease that already has or could permanently rob them of their vision. Today, the most common diseases in ...
Feb 27, 2012
0
0
Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.
Feb 13, 2012
0
0
Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure ...
Oct 24, 2011
0
1
